US Patent 7582667 Dihydrospiro[dibenzo[a,d][7]annulene-5,4′-imidazol] compounds for the inhibition of beta-secretase

Patent 7582667 was granted and assigned to Wyeth on September, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Wyeth

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

75826670

Patent Inventor Names

Dominick Anthony Quagliato0

Patrick Michael Andrae0

Yi Fan0

Date of Patent

September 1, 2009

Patent Application Number

117106660

Date Filed

February 23, 2007

Patent Citations Received

‌

US Patent 11891365 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

‌

US Patent 11702412 Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors

Patent Primary Examiner

‌

Golam M. M. Shameem

Patent abstract

The present invention provides a 10,11-dihydrospiro[dibenzo[a,d][7]annulene -5,4′-imidazol]-5′(1′H)-one compound of formula I

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7582667 Dihydrospiro[dibenzo[a,d][7]annulene-5,4′-imidazol] compounds for the inhibition of beta-secretase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API